Skip to: Content
Skip to: Site Navigation
Skip to: Search

July 24, 2008 11:48:54 PM CDT

Learn about Newser Points »

Stories related to: Wyeth

Stories

9 Stories

  • June 2008

    • Alzheimer's Drug Shows Some Promise

      newser  |  Wall Street Journal  |  Jun 17, 08 6:10 PM CDT

      Alzheimer's Drug Shows Some Promise

      A drug currently in experimental trials seems to be effective in battling Alzheimer's disease, the pharmaceutical companies developing it tell the Wall Street Journal . Bapineuzumab—developed by Elan and Wyeth—seems to be helpful in improving cognitive ability in those stricken by the disease, though much more so in patients who don't have a gene that increases risk of the brain disease. More »

      Tags

      Alzheimer's  • mental illness  • aging  • Wyeth  • drug trials

  • March 2008
  • February 2008

    • Feds OK Wyeth's New Antidepressant

      newser  |  New York Times  |  Feb 29, 08 7:41 PM CST

      Feds OK Wyeth's New Antidepressant

      Antidepressant Effexor XR will soon lose patent protection, and maker Wyeth is hoping Pristiq, the successor drug approved today by the FDA, will soften the financial blow. Higher-ups at the company gush over Pristiq's advantages, including zero acclimation time and no liver interaction, and hope that sales will offset losses to generic versions of Effexor, the New York Times reports. More »

      Tags

      stock market  • FDA  • antidepressant  • Wyeth  • metabolism  • Effexor  • patent expiration

    • Antidepressants Mostly Useless, Study Finds

      newser  |  Independent (UK)  |  Feb 26, 08 7:41 AM CST

      Antidepressants Mostly Useless, Study Finds

      Big Pharma swallowed a bitter pill yesterday as Prozac and other antidepressants were found in a UK study to be largely ineffectual in all but the most extreme cases of depression. The meta-analysis of 47 clinical trials submitted to the FDA with licensing applications for six popular antidepressants concluded that they should be prescribed only when all other treatments fail to yield results, the Independent reports. More »

    • Puerto Rican Drug Plants Shipped Tainted Pills: FDA

      newser  |  Associated Press  |  Feb 6, 08 1:38 PM CST

      Puerto Rican Drug Plants Shipped Tainted Pills: FDA

      The Caribbean island that produces 13 of the 20 best-selling drugs in the US has sold tainted pills and is struggling with quality control at its pharmaceutical plants, AP reports.  FDA inspections of 13 Puerto Rican plants between 2003 and 2007 revealed problems such as machinery pins left in drug bottles and foreign material embedded in tablets. More »

      Tags

      FDA  • Puerto Rico  • GlaxoSmithKline  • pharmaceutical  • Wyeth

  • January 2008
  • October 2007

    • Jury Adds Punitive $99M in Hormone Cancer Suit

      newser  |  Reuters  |  Oct 16, 07 3:27 AM CDT

      Jury Adds Punitive $99M in Hormone Cancer Suit

      A Nevada jury has tacked on an additional $99 million in punitive damages against the Wyeth pharmaceutical company after ruling in favor of three women who argued that the drug maker's hormone replacement therapy caused their breast cancer. That amount, added to compensatory damages determined last week, makes the total finding against the drug manufacturer $134.1 million. More »

    • Overdose Fears Prompt Recall of Infant Drugs

      newser  |  Reuters  |  Oct 11, 07 12:42 PM CDT

      Overdose Fears Prompt Recall of Infant Drugs

      Several drugmakers have recalled over-the-counter cough and cold products for infants over concerns about fatal overdoses, Reuters reports. Johnson & Johnson Wyeth and Novartis are among those recalling medicines; CVS said it will remove the products and generic equivalents. One professor took the criticism one step further: “There are really no good studies demonstrating that these medications work.” More »

      Tags

      drugs  • FDA  • recall  • pharmaceutical  • Wyeth  • Johnson and Johnson  • infants  • Novartis  • CVS

  • May 2007

9 Stories

Today's Most Popular

Loading...

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »